Gastrointestinal Stromal Tumor in Monozygotic Twins Shows Distinct Mutational Status: A Case Report

BACKGROUND Gastrointestinal stromal tumors (GISTs) are rare mesenchymal cancers that affect the gastrointestinal tract and are most often located in the stomach and proximal small intestine. The most common molecular genetic abnormalities underlying GIST carcinogenesis are mutations in the tyrosine...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of case reports 2021-03, Vol.22, p.e929887-e929887-7
Main Authors: Sobral-Leite, Marcelo, da Silva, Jesse Lopes, Pimenta-Inada, Haynna Kimie, Mendes Boisson, Andrea Sobral, Romeiro, Priscila de Almeida, Soares Parago, Fernando Mallet, Valadão da Silva, Marcus Vinicius M, de Melo, Andreia Cristina
Format: Article
Language:English
Subjects:
DNA Mutational Analysis
Female
Gastrointestinal Stromal Tumors - diagnosis
Gastrointestinal Stromal Tumors - genetics
Humans
Mutation
Proto-Oncogene Proteins c-kit - genetics
Receptor, Platelet-Derived Growth Factor alpha - genetics
Twins, Monozygotic - genetics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND Gastrointestinal stromal tumors (GISTs) are rare mesenchymal cancers that affect the gastrointestinal tract and are most often located in the stomach and proximal small intestine. The most common molecular genetic abnormalities underlying GIST carcinogenesis are mutations in the tyrosine kinase gene (KIT) and in the platelet-derived growth factor receptor alpha (PDGFRA) gene. To the best of our knowledge, no cases have been reported so far of synchronous diagnosis of GIST in 2 monozygotic twins presenting with clinical and morphological features of sporadic disease. CASE REPORT This report presents the cases of 2 monozygotic twin sisters who were diagnosed with GIST at the same age and who had different KIT exon 11 tumor mutational statuses. In the current report, the screening examination that led to early detection of GIST in one of the sisters was not motivated by any symptom, but by a GIST diagnosis in her twin a few days before. The literature was reviewed for pathological and molecular features associated with prognosis and treatment response. Furthermore, we identified identical genotypes of KIT and PDGFRA polymorphisms in the DNA of both tumors that might be present in the germline DNA. The present case supports the implementation of specific cancer screening in the context of monozygotic twins, regardless of identification of the genetic components involved. CONCLUSIONS Our report suggests that monozygotic twins with GIST can have different mutational statuses for KIT and PDGFRA. Referral for special screening should be considered for individuals who have a monozygotic twin diagnosed with cancer.
ISSN:1941-5923
1941-5923
DOI:10.12659/AJCR.929887